Page 16 - Applied Pharmacognosy
P. 16
Commission E monographs:
•All data available to the health authority (data
from pharmaceutical companies interested in a
particular drug, new data from pharmacological
and clinical research publications, data from the international
side-effect monitoring system, etc.) were collected and
forwarded to Commission E.
•An ideal situation is reflected in the so-called "positive
monograph" covering all relevant indications for the package
leaflet or consumer information such as composition of the drug,
indications, contra-indications, warnings, dosage.
